Here's Why The World Is Running Low On Snakebite Anti-Venom
An effective brand of medicine that treats bites from venomous snakes is running low. Here's why it might take a while to find a replacement.By Samantha Crook | September 9, 2015
Doctors Without Borders announced this week the supply of medicine that can save your life after a venomous snakebite is running critically low.
Sanofi, the manufacturer behind the safest and most effective anti-venom, called Fav-Afrique, is cycling through its last batch of the much-needed snake bite medicine. (Video via Sanofi)
According to Doctors Without Borders, Sanofi stopped production of the anti-venom in 2010 and the decision wasn't made public until years later. The last batch expires in June 2016.